Premium
Methods report: European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC
Author(s) -
Dressler C.,
Rosumeck S.,
Werner R.N.,
Kraaij G.,
Lumig P.,
Wakkee M.,
Spuls P.,
Nast A.
Publication year - 2017
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.14470
Subject(s) - secukinumab , medicine , apremilast , guideline , psoriasis , immunology , psoriatic arthritis , pathology